Sector | Healthcare |
Industry | - |
Day Range | 4.79 | 5.76 |
52-Wk Range | 1.97 | 12.49 |
Last Close | 4.82 |
Mkt Cap (m) | 1,093.06 |
Dividend yield | - |
ISIN | IE00BJ3V9050 |
Volume | 47 |
Exchange Venue | NAS |
Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.
Price/Earning | - |
Price/Book | 0.00 |
Price/Sales | 0.37 |
P/CF | 5.73 |
Rev Growth (3 year avg) | -3.39 |
EPS Growth (3 year avg) | - |
Operating Margin % | 16.41 |
Net Margin % | -35.00 |
Return on Equity | - |
Debt/Equity | - |
en 08/08/2018 |
en 31/12/2018 |
USD | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Revenue (m) | 2,617 | 2,877 | 3,269 | 4,010 | 3,469 | 2,947 |
Operating Income (m) | 586 | 527 | 350 | 421 | 438 | 484 |
Net Income (m) | -685 | -721 | -1,495 | -3,347 | -2,035 | -1,031 |
Basic EPS | -6.05 | -4.91 | -7.59 | -15.03 | -9.12 | -4.61 |
Avg. Diluted Shares Outstanding (m) | 113 | 147 | 197 | 223 | 223 | 224 |
USD | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Current Assets (m) | 2,855 | 3,307 | 3,475 | 2,589 | 2,271 | 2,343 |
Non Current Assets (m) | 3,717 | 7,602 | 15,875 | 11,686 | 9,365 | 7,789 |
Total Assets (m) | 6,572 | 10,910 | 19,350 | 14,275 | 11,636 | 10,132 |
Current Liabilities (m) | 1,697 | 3,099 | 3,474 | 2,635 | 2,221 | 1,950 |
Total Liabilities (m) | - | - | - | - | - | - |
Total Equity (m) | 526 | 2,375 | 5,968 | 2,702 | 485 | -498 |
USD | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
Operating Cash Flows (m) | 299 | 338 | 62 | 524 | 554 | 267 |
Capital Expenditure (m) | -108 | -85 | -126 | -158 | -126 | -86 |